Researcher use AI to predict Alzheimer's disease progression
Author
Kyle Wiggers
Published
February 2, 2019
Researchers at Unlearn.AI, a startup that designs software tools for clinical research, think that artificial intelligence has a valuable role to play in personalizing diagnosis and treatment.
A fascinating approach to the problem of how to make clinical trials more efficient, and understand more about what may be possible with more and better patient data.
